170103_PHARMAUST LIMITED (ASX- PAA) - SECONDARY TRADING NOTICE PURSUANT TO SECTION 708A(5)(e) OF THE CORPORATIONS ACT 2001
investorenquiries@pharmaust.com+61 8 9202 6814
PharmAust (PAA)
- HOME
- ABOUT
- PIPELINE & TRIALS
- INVESTOR CENTRE
- MEDIA
- Podcast Episode 18: Dr Kim Agnew, PharmAust
- Fireside Chat with Dr Roger Aston
- Fireside Chat with Dr Kim
- PharmAust Webinar
- Epichem Webinar
- BB PAA Video – September 2021
- OHD Benchtop Flow Reactor Launch
- Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
- Interview with TechInvest – May 2020
- Dr. Richard Mollard – 6IX Interview March 2020
- PharmAust In the News
- PharmAust Videos
- PharmAust New Cancer Treatment
- PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
- PharmAust on Youtube
- CONTACT
- HOME
- ABOUT
- PIPELINE & TRIALS
- INVESTOR CENTRE
- MEDIA
- Podcast Episode 18: Dr Kim Agnew, PharmAust
- Fireside Chat with Dr Roger Aston
- Fireside Chat with Dr Kim
- PharmAust Webinar
- Epichem Webinar
- BB PAA Video – September 2021
- OHD Benchtop Flow Reactor Launch
- Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
- Interview with TechInvest – May 2020
- Dr. Richard Mollard – 6IX Interview March 2020
- PharmAust In the News
- PharmAust Videos
- PharmAust New Cancer Treatment
- PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
- PharmAust on Youtube
- CONTACT